PrEPared to choose: the protocol for an implementation study of the delivery of cabotegravir long-acting injectable pre-exposure prophylaxis (PrEP) as an HIV prevention product option within a real world PrEP choice context in cape town

By afschroeder • September 25, 2025

Pike C, Rousseau E, Macdonald P, Mapukata P, Lebelo K, Joseph-Davey D, Little F, Bekker LG. PrEPared to choose: the protocol for an implementation study of the delivery of cabotegravir long-acting injectable pre-exposure prophylaxis (PrEP) as an HIV prevention product option within a real world PrEP choice context in cape town. BMC Public Health. 2025 Sep 24;25(1):3109. doi: 10.1186/s12889-025-24370-z. PMID: 40993613.

Tags: Adolescents and young people, HIV prevention, Infectious Diseases, Injectable PrEP, PrEP choice, Publications, south africa

Advancing the inclusion of pregnant and lactating populations in HIV PrEP research: ethical, regulatory, and surveillance recommendations from a multisectoral working group

Osakwe CE, Schaefer R, Donaldson L, Abiodun AS, Chatani-Gada M, Chigome AK, Day S, Deaton C, Elemuwa UG, Ingold H, Joseph Davey D, Kersey K,[...]

A Community-Based Intervention to Increase PrEP Initiation and Reduce Internalized Stigma: A Randomized Trial Among Black Sexual Minority Men in Prince George’s County, Maryland

Turpin RE, Wilson GT, Davidson Mhonde RR, Camp AD, Dyer TV, Mayer KH, Liu H, Coates T, Boekeloo B. A Community-Based Intervention to Increase PrEP[...]

Altered bile acid metabolism in people with HIV correlates with systemic and intestinal inflammation

Irwin S, Elliott J, Li F, Ruiz P, Anton PA, Du X, Fulcher JA. Altered bile acid metabolism in people with HIV correlates with systemic[...]